Reports for MYLAN PHARMACEUTICALS ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
643 |
|
| Actual shortage: | 17 (3%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 85 (13%) | |
| Resolved: | 541 (84%) | |
Discontinuation Reports |
233 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 233 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
80 (9%) |
|
Overdue reports |
1 (6%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL | 300MG 200MG | TABLET | Resolved | 2019-04-23 | 2019-06-26 | 82201 |
| MYLAN-MIRTAZAPINE | 15MG | TABLET | Resolved | 2019-04-23 | 2019-05-01 | 82204 |
| MYLAN-RIVASTIGMINE PATCH 5 | 9MG | PATCH | Resolved | 2019-05-08 | 2019-07-10 | 83409 |
| MYLAN-RIVASTIGMINE PATCH 10 | 18MG | PATCH | Resolved | 2019-05-08 | 2019-07-30 | 83413 |
| MOVISSE | 0.35MG | TABLET | Resolved | 2019-05-14 | 2019-08-31 | 84070 |
| FREYA 21 | 0.15MG 0.03MG | TABLET | Resolved | 2019-05-22 | 2019-05-29 | 84512 |
| INDAYO | 0.03MG 0.15MG | TABLET | Resolved | 2019-05-22 | 2019-06-19 | 84515 |
| MYLAN-INDAPAMIDE | 1.25MG | TABLET | Resolved | 2019-05-28 | 2019-08-14 | 84997 |
| MYLAN-ABACAVIR/LAMIVUDINE | 600MG 300MG | TABLET | Resolved | 2019-05-28 | 2019-06-19 | 85021 |
| MYLAN-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2019-05-28 | 2019-06-19 | 85054 |
| MYLAN-MIRTAZAPINE | 15MG | TABLET | Resolved | 2019-05-28 | 2019-07-17 | 85061 |
| FREYA 21 | 0.15MG 0.03MG | TABLET | Resolved | 2019-06-04 | 2019-06-19 | 85557 |
| MYLAN-PANTOPRAZOLE T | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2019-06-04 | 2019-06-19 | 85560 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 500MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2019-06-25 | 2019-07-17 | 87460 |
| MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE | 600MG 300MG 200MG | TABLET | Resolved | 2019-06-25 | 2019-07-03 | 87463 |
| MYLAN-BECLO AQ | 50MCG | METERED-DOSE AEROSOL SUSPENSION | Resolved | 2019-06-25 | 2019-07-03 | 87466 |
| MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL | 300MG 200MG | TABLET | Resolved | 2019-07-03 | 2019-07-10 | 88291 |
| MYLAN-VERAPAMIL | 120MG | TABLET | Resolved | 2019-07-03 | 2019-10-16 | 88302 |
| CLARUS | 10MG | CAPSULE | Resolved | 2019-07-09 | 2019-07-17 | 88979 |
| MYLAN-BECLO AQ | 50MCG | METERED-DOSE AEROSOL SUSPENSION | Resolved | 2019-07-09 | 2019-07-24 | 88982 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-RISPERIDONE ODT | 0.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149759 |
| MYLAN-RISPERIDONE ODT | 1MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149762 |
| MYLAN-RISPERIDONE ODT | 2MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149765 |
| MYLAN-RISPERIDONE ODT | 3MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149768 |
| MYLAN-RISPERIDONE ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149771 |
| TOBRAMYCIN INJECTION, USP | 40MG | SOLUTION | Discontinued | 2022-01-12 | 2022-01-12 | 152485 |
| MYLAN-TOLTERODINE ER | 2MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2022-02-15 | 2022-02-15 | 155037 |
| MYLAN-TOLTERODINE ER | 4MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2022-02-15 | 2022-02-15 | 155040 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160318 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160323 |
| MYLAN-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-08-25 | 2022-08-25 | 167806 |
| MYLAN-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-08-25 | 2022-08-25 | 167819 |
| MYLAN-VERAPAMIL | 80MG | TABLET | Discontinued | 2024-04-11 | 2024-04-12 | 224846 |